10 Sep 2021
Oncomine Dx Target Test Receives MHLW Approval as a Companion Diagnostic for Eli Lilly’s RET-Inhibitor in Non-Small Cell Lung Cancer in Japan
Author: admintech | Filed under: Press ReleaseCARLSBAD, Calif., Sept. 10, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced the Japan Ministry of Health, Labour and Welfare (MHLW), Japan’s regulatory agency, has granted approval for the Oncomine Dx Target Test as a next-generation sequencing (NGS)-based companion…